nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—ABCB1—kidney cancer	0.151	1	CbGaD
Dronedarone—ABCB1—Temsirolimus—kidney cancer	0.0393	0.0854	CbGbCtD
Dronedarone—KCNH2—Sunitinib—kidney cancer	0.0389	0.0845	CbGbCtD
Dronedarone—CYP2D6—Temsirolimus—kidney cancer	0.0371	0.0805	CbGbCtD
Dronedarone—CYP3A4—Everolimus—kidney cancer	0.0349	0.0758	CbGbCtD
Dronedarone—ALB—Erlotinib—kidney cancer	0.0282	0.0612	CbGbCtD
Dronedarone—CYP3A4—Temsirolimus—kidney cancer	0.0236	0.0512	CbGbCtD
Dronedarone—ABCB1—Pazopanib—kidney cancer	0.0207	0.0449	CbGbCtD
Dronedarone—CYP2D6—Pazopanib—kidney cancer	0.0195	0.0423	CbGbCtD
Dronedarone—ABCB1—Dactinomycin—kidney cancer	0.0189	0.041	CbGbCtD
Dronedarone—ABCB1—Gemcitabine—kidney cancer	0.0149	0.0324	CbGbCtD
Dronedarone—ABCB1—Erlotinib—kidney cancer	0.0147	0.032	CbGbCtD
Dronedarone—CYP2D6—Erlotinib—kidney cancer	0.0139	0.0302	CbGbCtD
Dronedarone—ABCB1—Paclitaxel—kidney cancer	0.0135	0.0293	CbGbCtD
Dronedarone—CYP3A4—Pazopanib—kidney cancer	0.0124	0.0269	CbGbCtD
Dronedarone—ABCB1—Sorafenib—kidney cancer	0.012	0.026	CbGbCtD
Dronedarone—ABCB1—Vinblastine—kidney cancer	0.0118	0.0257	CbGbCtD
Dronedarone—ABCB1—Vincristine—kidney cancer	0.0116	0.0253	CbGbCtD
Dronedarone—CYP2D6—Sorafenib—kidney cancer	0.0113	0.0245	CbGbCtD
Dronedarone—CYP2D6—Vinblastine—kidney cancer	0.0112	0.0242	CbGbCtD
Dronedarone—ABCB1—Sunitinib—kidney cancer	0.00972	0.0211	CbGbCtD
Dronedarone—CYP3A4—Erlotinib—kidney cancer	0.00884	0.0192	CbGbCtD
Dronedarone—CYP3A4—Paclitaxel—kidney cancer	0.00809	0.0176	CbGbCtD
Dronedarone—ABCB1—Doxorubicin—kidney cancer	0.00728	0.0158	CbGbCtD
Dronedarone—CYP3A4—Sorafenib—kidney cancer	0.00718	0.0156	CbGbCtD
Dronedarone—CYP3A4—Vinblastine—kidney cancer	0.00709	0.0154	CbGbCtD
Dronedarone—CYP3A4—Vincristine—kidney cancer	0.00697	0.0151	CbGbCtD
Dronedarone—CYP2D6—Doxorubicin—kidney cancer	0.00686	0.0149	CbGbCtD
Dronedarone—CYP3A4—Sunitinib—kidney cancer	0.00582	0.0126	CbGbCtD
Dronedarone—CYP3A4—Doxorubicin—kidney cancer	0.00436	0.00946	CbGbCtD
Dronedarone—HCN4—cardiac atrium—kidney cancer	0.00426	0.145	CbGeAlD
Dronedarone—HCN3—cortex of kidney—kidney cancer	0.00362	0.123	CbGeAlD
Dronedarone—HCN2—cardiac atrium—kidney cancer	0.00323	0.11	CbGeAlD
Dronedarone—CYP3A4—urine—kidney cancer	0.00149	0.0504	CbGeAlD
Dronedarone—CYP2D6—urine—kidney cancer	0.00146	0.0496	CbGeAlD
Dronedarone—CACNB2—cortex of kidney—kidney cancer	0.00115	0.039	CbGeAlD
Dronedarone—CACNB2—cardiac atrium—kidney cancer	0.00109	0.0371	CbGeAlD
Dronedarone—ADRA1B—renal system—kidney cancer	0.00108	0.0367	CbGeAlD
Dronedarone—ADRA1B—kidney—kidney cancer	0.00105	0.0355	CbGeAlD
Dronedarone—CACNA1D—cardiac atrium—kidney cancer	0.000955	0.0324	CbGeAlD
Dronedarone—CACNA1C—cardiac atrium—kidney cancer	0.000882	0.0299	CbGeAlD
Dronedarone—ADRB1—cardiac atrium—kidney cancer	0.000688	0.0234	CbGeAlD
Dronedarone—Skin disorder—Pazopanib—kidney cancer	0.000639	0.00294	CcSEcCtD
Dronedarone—ADRA2C—nephron tubule—kidney cancer	0.000637	0.0216	CbGeAlD
Dronedarone—Erythema—Everolimus—kidney cancer	0.000636	0.00293	CcSEcCtD
Dronedarone—Mediastinal disorder—Erlotinib—kidney cancer	0.000635	0.00293	CcSEcCtD
Dronedarone—Dysgeusia—Everolimus—kidney cancer	0.000623	0.00287	CcSEcCtD
Dronedarone—Bradycardia—Sunitinib—kidney cancer	0.000621	0.00286	CcSEcCtD
Dronedarone—Erythema—Erlotinib—kidney cancer	0.000614	0.00283	CcSEcCtD
Dronedarone—ADRA1A—renal system—kidney cancer	0.000608	0.0206	CbGeAlD
Dronedarone—Cardiac failure—Paclitaxel—kidney cancer	0.000607	0.0028	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.000603	0.00278	CcSEcCtD
Dronedarone—Fatigue—Temsirolimus—kidney cancer	0.000602	0.00277	CcSEcCtD
Dronedarone—Photosensitivity reaction—Vincristine—kidney cancer	0.000589	0.00271	CcSEcCtD
Dronedarone—Cardiac disorder—Sorafenib—kidney cancer	0.000589	0.00271	CcSEcCtD
Dronedarone—KCNH2—renal system—kidney cancer	0.000587	0.0199	CbGeAlD
Dronedarone—Dermatitis atopic—Doxorubicin—kidney cancer	0.000584	0.00269	CcSEcCtD
Dronedarone—Angioedema—Everolimus—kidney cancer	0.000581	0.00268	CcSEcCtD
Dronedarone—ADRA2C—renal system—kidney cancer	0.000579	0.0196	CbGeAlD
Dronedarone—Dyspepsia—Pazopanib—kidney cancer	0.000579	0.00267	CcSEcCtD
Dronedarone—Pneumonia—Vincristine—kidney cancer	0.000578	0.00267	CcSEcCtD
Dronedarone—Angiopathy—Sorafenib—kidney cancer	0.000576	0.00265	CcSEcCtD
Dronedarone—Immune system disorder—Sorafenib—kidney cancer	0.000573	0.00264	CcSEcCtD
Dronedarone—Mediastinal disorder—Sorafenib—kidney cancer	0.000572	0.00263	CcSEcCtD
Dronedarone—Gastrointestinal pain—Temsirolimus—kidney cancer	0.000571	0.00263	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000568	0.00262	CcSEcCtD
Dronedarone—Fatigue—Pazopanib—kidney cancer	0.000567	0.00261	CcSEcCtD
Dronedarone—Cardiac disorder—Sunitinib—kidney cancer	0.000567	0.00261	CcSEcCtD
Dronedarone—Rash erythematous—Doxorubicin—kidney cancer	0.000564	0.0026	CcSEcCtD
Dronedarone—Amiodarone—CYP1A1—kidney cancer	0.000562	0.653	CrCbGaD
Dronedarone—ADRA2C—kidney—kidney cancer	0.00056	0.019	CbGeAlD
Dronedarone—Blood creatinine increased—Paclitaxel—kidney cancer	0.000555	0.00256	CcSEcCtD
Dronedarone—Angiopathy—Sunitinib—kidney cancer	0.000554	0.00255	CcSEcCtD
Dronedarone—Erythema—Sorafenib—kidney cancer	0.000552	0.00254	CcSEcCtD
Dronedarone—Abdominal pain—Temsirolimus—kidney cancer	0.000552	0.00254	CcSEcCtD
Dronedarone—Immune system disorder—Sunitinib—kidney cancer	0.000551	0.00254	CcSEcCtD
Dronedarone—Mediastinal disorder—Sunitinib—kidney cancer	0.00055	0.00253	CcSEcCtD
Dronedarone—Pneumonia—Gemcitabine—kidney cancer	0.000549	0.00253	CcSEcCtD
Dronedarone—ADRA2C—cortex of kidney—kidney cancer	0.000545	0.0185	CbGeAlD
Dronedarone—Dysgeusia—Sorafenib—kidney cancer	0.000541	0.00249	CcSEcCtD
Dronedarone—Hypokalaemia—Paclitaxel—kidney cancer	0.000539	0.00249	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000538	0.00248	CcSEcCtD
Dronedarone—Gastrointestinal pain—Pazopanib—kidney cancer	0.000538	0.00248	CcSEcCtD
Dronedarone—Ageusia—Doxorubicin—kidney cancer	0.000533	0.00246	CcSEcCtD
Dronedarone—Erythema—Sunitinib—kidney cancer	0.000531	0.00245	CcSEcCtD
Dronedarone—KCNH2—cardiac atrium—kidney cancer	0.000525	0.0178	CbGeAlD
Dronedarone—Dysgeusia—Sunitinib—kidney cancer	0.00052	0.0024	CcSEcCtD
Dronedarone—Abdominal pain—Pazopanib—kidney cancer	0.00052	0.00239	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.000519	0.00239	CcSEcCtD
Dronedarone—ADRA2C—cardiac atrium—kidney cancer	0.000518	0.0176	CbGeAlD
Dronedarone—Hepatobiliary disease—Gemcitabine—kidney cancer	0.000516	0.00238	CcSEcCtD
Dronedarone—Liver injury—Doxorubicin—kidney cancer	0.000513	0.00237	CcSEcCtD
Dronedarone—Nervous system disorder—Everolimus—kidney cancer	0.000509	0.00235	CcSEcCtD
Dronedarone—Angioedema—Sorafenib—kidney cancer	0.000505	0.00232	CcSEcCtD
Dronedarone—Skin disorder—Everolimus—kidney cancer	0.000504	0.00232	CcSEcCtD
Dronedarone—Erythema—Dactinomycin—kidney cancer	0.000503	0.00232	CcSEcCtD
Dronedarone—Asthenia—Temsirolimus—kidney cancer	0.000501	0.00231	CcSEcCtD
Dronedarone—Cardiac failure—Capecitabine—kidney cancer	0.000498	0.0023	CcSEcCtD
Dronedarone—Pruritus—Temsirolimus—kidney cancer	0.000494	0.00228	CcSEcCtD
Dronedarone—Nervous system disorder—Erlotinib—kidney cancer	0.000491	0.00226	CcSEcCtD
Dronedarone—Skin disorder—Erlotinib—kidney cancer	0.000487	0.00224	CcSEcCtD
Dronedarone—Angioedema—Sunitinib—kidney cancer	0.000486	0.00224	CcSEcCtD
Dronedarone—Cardiac disorder—Vincristine—kidney cancer	0.000479	0.00221	CcSEcCtD
Dronedarone—Diarrhoea—Temsirolimus—kidney cancer	0.000478	0.0022	CcSEcCtD
Dronedarone—Asthenia—Pazopanib—kidney cancer	0.000472	0.00217	CcSEcCtD
Dronedarone—Angiopathy—Vincristine—kidney cancer	0.000468	0.00216	CcSEcCtD
Dronedarone—Photosensitivity reaction—Paclitaxel—kidney cancer	0.000468	0.00215	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000467	0.00215	CcSEcCtD
Dronedarone—Mediastinal disorder—Vincristine—kidney cancer	0.000465	0.00214	CcSEcCtD
Dronedarone—Pruritus—Pazopanib—kidney cancer	0.000465	0.00214	CcSEcCtD
Dronedarone—Pneumonia—Paclitaxel—kidney cancer	0.000459	0.00212	CcSEcCtD
Dronedarone—Dyspepsia—Everolimus—kidney cancer	0.000457	0.00211	CcSEcCtD
Dronedarone—Blood creatinine increased—Capecitabine—kidney cancer	0.000456	0.0021	CcSEcCtD
Dronedarone—Cardiac disorder—Gemcitabine—kidney cancer	0.000455	0.00209	CcSEcCtD
Dronedarone—Anaphylactic shock—Sorafenib—kidney cancer	0.000451	0.00208	CcSEcCtD
Dronedarone—Diarrhoea—Pazopanib—kidney cancer	0.00045	0.00207	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000449	0.00207	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Everolimus—kidney cancer	0.000448	0.00207	CcSEcCtD
Dronedarone—Fatigue—Everolimus—kidney cancer	0.000448	0.00206	CcSEcCtD
Dronedarone—Angiopathy—Gemcitabine—kidney cancer	0.000444	0.00205	CcSEcCtD
Dronedarone—Vomiting—Temsirolimus—kidney cancer	0.000444	0.00204	CcSEcCtD
Dronedarone—Hypokalaemia—Capecitabine—kidney cancer	0.000443	0.00204	CcSEcCtD
Dronedarone—Immune system disorder—Gemcitabine—kidney cancer	0.000442	0.00204	CcSEcCtD
Dronedarone—Nervous system disorder—Sorafenib—kidney cancer	0.000442	0.00204	CcSEcCtD
Dronedarone—Mediastinal disorder—Gemcitabine—kidney cancer	0.000441	0.00203	CcSEcCtD
Dronedarone—Dyspepsia—Erlotinib—kidney cancer	0.000441	0.00203	CcSEcCtD
Dronedarone—Rash—Temsirolimus—kidney cancer	0.00044	0.00203	CcSEcCtD
Dronedarone—Dermatitis—Temsirolimus—kidney cancer	0.00044	0.00203	CcSEcCtD
Dronedarone—Skin disorder—Sorafenib—kidney cancer	0.000438	0.00202	CcSEcCtD
Dronedarone—ADRA2A—cortex of kidney—kidney cancer	0.000435	0.0148	CbGeAlD
Dronedarone—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000433	0.00199	CcSEcCtD
Dronedarone—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000432	0.00199	CcSEcCtD
Dronedarone—Fatigue—Erlotinib—kidney cancer	0.000432	0.00199	CcSEcCtD
Dronedarone—Erythema—Gemcitabine—kidney cancer	0.000426	0.00196	CcSEcCtD
Dronedarone—Gastrointestinal pain—Vinblastine—kidney cancer	0.000426	0.00196	CcSEcCtD
Dronedarone—Nervous system disorder—Sunitinib—kidney cancer	0.000425	0.00196	CcSEcCtD
Dronedarone—Gastrointestinal pain—Everolimus—kidney cancer	0.000425	0.00196	CcSEcCtD
Dronedarone—Skin disorder—Sunitinib—kidney cancer	0.000421	0.00194	CcSEcCtD
Dronedarone—Vomiting—Pazopanib—kidney cancer	0.000418	0.00193	CcSEcCtD
Dronedarone—Bradycardia—Paclitaxel—kidney cancer	0.000417	0.00192	CcSEcCtD
Dronedarone—Rash—Pazopanib—kidney cancer	0.000415	0.00191	CcSEcCtD
Dronedarone—Nausea—Temsirolimus—kidney cancer	0.000415	0.00191	CcSEcCtD
Dronedarone—Dermatitis—Pazopanib—kidney cancer	0.000414	0.00191	CcSEcCtD
Dronedarone—ADRA2A—gonad—kidney cancer	0.000414	0.0141	CbGeAlD
Dronedarone—ADRA2A—cardiac atrium—kidney cancer	0.000414	0.014	CbGeAlD
Dronedarone—Abdominal pain—Vinblastine—kidney cancer	0.000412	0.0019	CcSEcCtD
Dronedarone—Abdominal pain—Everolimus—kidney cancer	0.00041	0.00189	CcSEcCtD
Dronedarone—Gastrointestinal pain—Erlotinib—kidney cancer	0.00041	0.00189	CcSEcCtD
Dronedarone—Dyspepsia—Sorafenib—kidney cancer	0.000397	0.00183	CcSEcCtD
Dronedarone—Abdominal pain—Erlotinib—kidney cancer	0.000396	0.00182	CcSEcCtD
Dronedarone—Nausea—Pazopanib—kidney cancer	0.000391	0.0018	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000389	0.00179	CcSEcCtD
Dronedarone—Fatigue—Sorafenib—kidney cancer	0.000389	0.00179	CcSEcCtD
Dronedarone—Photosensitivity reaction—Capecitabine—kidney cancer	0.000384	0.00177	CcSEcCtD
Dronedarone—Dyspepsia—Sunitinib—kidney cancer	0.000382	0.00176	CcSEcCtD
Dronedarone—Cardiac disorder—Paclitaxel—kidney cancer	0.000381	0.00175	CcSEcCtD
Dronedarone—Pneumonia—Capecitabine—kidney cancer	0.000377	0.00174	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000374	0.00172	CcSEcCtD
Dronedarone—Asthenia—Vinblastine—kidney cancer	0.000374	0.00172	CcSEcCtD
Dronedarone—Fatigue—Sunitinib—kidney cancer	0.000374	0.00172	CcSEcCtD
Dronedarone—Asthenia—Everolimus—kidney cancer	0.000373	0.00172	CcSEcCtD
Dronedarone—Angiopathy—Paclitaxel—kidney cancer	0.000372	0.00171	CcSEcCtD
Dronedarone—Immune system disorder—Paclitaxel—kidney cancer	0.00037	0.00171	CcSEcCtD
Dronedarone—Mediastinal disorder—Paclitaxel—kidney cancer	0.00037	0.0017	CcSEcCtD
Dronedarone—Gastrointestinal pain—Sorafenib—kidney cancer	0.000369	0.0017	CcSEcCtD
Dronedarone—Pruritus—Everolimus—kidney cancer	0.000367	0.00169	CcSEcCtD
Dronedarone—Anaphylactic shock—Vincristine—kidney cancer	0.000367	0.00169	CcSEcCtD
Dronedarone—CYP3A4—renal system—kidney cancer	0.000364	0.0123	CbGeAlD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00036	0.00166	CcSEcCtD
Dronedarone—Nervous system disorder—Vincristine—kidney cancer	0.00036	0.00166	CcSEcCtD
Dronedarone—Asthenia—Erlotinib—kidney cancer	0.000359	0.00166	CcSEcCtD
Dronedarone—CYP2D6—renal system—kidney cancer	0.000358	0.0121	CbGeAlD
Dronedarone—Erythema—Paclitaxel—kidney cancer	0.000357	0.00164	CcSEcCtD
Dronedarone—Diarrhoea—Vinblastine—kidney cancer	0.000357	0.00164	CcSEcCtD
Dronedarone—Abdominal pain—Sorafenib—kidney cancer	0.000356	0.00164	CcSEcCtD
Dronedarone—Diarrhoea—Everolimus—kidney cancer	0.000355	0.00164	CcSEcCtD
Dronedarone—Gastrointestinal pain—Sunitinib—kidney cancer	0.000355	0.00163	CcSEcCtD
Dronedarone—Hepatobiliary disease—Capecitabine—kidney cancer	0.000355	0.00163	CcSEcCtD
Dronedarone—Pruritus—Erlotinib—kidney cancer	0.000354	0.00163	CcSEcCtD
Dronedarone—Fatigue—Dactinomycin—kidney cancer	0.000354	0.00163	CcSEcCtD
Dronedarone—CYP3A4—kidney—kidney cancer	0.000352	0.0119	CbGeAlD
Dronedarone—Dysgeusia—Paclitaxel—kidney cancer	0.00035	0.00161	CcSEcCtD
Dronedarone—Eczema—Doxorubicin—kidney cancer	0.000349	0.00161	CcSEcCtD
Dronedarone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000348	0.0016	CcSEcCtD
Dronedarone—CYP2D6—kidney—kidney cancer	0.000346	0.0117	CbGeAlD
Dronedarone—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000346	0.00159	CcSEcCtD
Dronedarone—Abdominal pain—Sunitinib—kidney cancer	0.000343	0.00158	CcSEcCtD
Dronedarone—Diarrhoea—Erlotinib—kidney cancer	0.000343	0.00158	CcSEcCtD
Dronedarone—Bradycardia—Capecitabine—kidney cancer	0.000343	0.00158	CcSEcCtD
Dronedarone—Nervous system disorder—Gemcitabine—kidney cancer	0.000341	0.00157	CcSEcCtD
Dronedarone—Skin disorder—Gemcitabine—kidney cancer	0.000338	0.00156	CcSEcCtD
Dronedarone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000336	0.00155	CcSEcCtD
Dronedarone—Vomiting—Vinblastine—kidney cancer	0.000331	0.00153	CcSEcCtD
Dronedarone—Vomiting—Everolimus—kidney cancer	0.00033	0.00152	CcSEcCtD
Dronedarone—Rash—Everolimus—kidney cancer	0.000327	0.00151	CcSEcCtD
Dronedarone—Dermatitis—Everolimus—kidney cancer	0.000327	0.00151	CcSEcCtD
Dronedarone—Angioedema—Paclitaxel—kidney cancer	0.000326	0.0015	CcSEcCtD
Dronedarone—Abdominal pain—Dactinomycin—kidney cancer	0.000325	0.0015	CcSEcCtD
Dronedarone—Asthenia—Sorafenib—kidney cancer	0.000323	0.00149	CcSEcCtD
Dronedarone—Cardiac failure—Doxorubicin—kidney cancer	0.000321	0.00148	CcSEcCtD
Dronedarone—Pruritus—Sorafenib—kidney cancer	0.000319	0.00147	CcSEcCtD
Dronedarone—Vomiting—Erlotinib—kidney cancer	0.000319	0.00147	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Vincristine—kidney cancer	0.000317	0.00146	CcSEcCtD
Dronedarone—Fatigue—Vincristine—kidney cancer	0.000316	0.00146	CcSEcCtD
Dronedarone—Rash—Erlotinib—kidney cancer	0.000316	0.00146	CcSEcCtD
Dronedarone—Dermatitis—Erlotinib—kidney cancer	0.000316	0.00145	CcSEcCtD
Dronedarone—Cardiac disorder—Capecitabine—kidney cancer	0.000312	0.00144	CcSEcCtD
Dronedarone—Asthenia—Sunitinib—kidney cancer	0.000311	0.00143	CcSEcCtD
Dronedarone—Nausea—Vinblastine—kidney cancer	0.00031	0.00143	CcSEcCtD
Dronedarone—Nausea—Everolimus—kidney cancer	0.000308	0.00142	CcSEcCtD
Dronedarone—Diarrhoea—Sorafenib—kidney cancer	0.000308	0.00142	CcSEcCtD
Dronedarone—Pruritus—Sunitinib—kidney cancer	0.000307	0.00141	CcSEcCtD
Dronedarone—Angiopathy—Capecitabine—kidney cancer	0.000305	0.00141	CcSEcCtD
Dronedarone—Immune system disorder—Capecitabine—kidney cancer	0.000304	0.0014	CcSEcCtD
Dronedarone—Mediastinal disorder—Capecitabine—kidney cancer	0.000303	0.0014	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000302	0.00139	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.0003	0.00138	CcSEcCtD
Dronedarone—Fatigue—Gemcitabine—kidney cancer	0.0003	0.00138	CcSEcCtD
Dronedarone—Gastrointestinal pain—Vincristine—kidney cancer	0.0003	0.00138	CcSEcCtD
Dronedarone—Amiodarone—ABCB1—kidney cancer	0.000299	0.347	CrCbGaD
Dronedarone—Nausea—Erlotinib—kidney cancer	0.000298	0.00137	CcSEcCtD
Dronedarone—Diarrhoea—Sunitinib—kidney cancer	0.000297	0.00137	CcSEcCtD
Dronedarone—Asthenia—Dactinomycin—kidney cancer	0.000295	0.00136	CcSEcCtD
Dronedarone—Blood creatinine increased—Doxorubicin—kidney cancer	0.000294	0.00135	CcSEcCtD
Dronedarone—Erythema—Capecitabine—kidney cancer	0.000293	0.00135	CcSEcCtD
Dronedarone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000291	0.00134	CcSEcCtD
Dronedarone—Abdominal pain—Vincristine—kidney cancer	0.00029	0.00134	CcSEcCtD
Dronedarone—Dysgeusia—Capecitabine—kidney cancer	0.000287	0.00132	CcSEcCtD
Dronedarone—Vomiting—Sorafenib—kidney cancer	0.000287	0.00132	CcSEcCtD
Dronedarone—Nervous system disorder—Paclitaxel—kidney cancer	0.000286	0.00132	CcSEcCtD
Dronedarone—Hypokalaemia—Doxorubicin—kidney cancer	0.000285	0.00131	CcSEcCtD
Dronedarone—Rash—Sorafenib—kidney cancer	0.000284	0.00131	CcSEcCtD
Dronedarone—Dermatitis—Sorafenib—kidney cancer	0.000284	0.00131	CcSEcCtD
Dronedarone—ABCB1—nephron tubule—kidney cancer	0.000283	0.00961	CbGeAlD
Dronedarone—Skin disorder—Paclitaxel—kidney cancer	0.000283	0.0013	CcSEcCtD
Dronedarone—Diarrhoea—Dactinomycin—kidney cancer	0.000281	0.00129	CcSEcCtD
Dronedarone—Vomiting—Sunitinib—kidney cancer	0.000276	0.00127	CcSEcCtD
Dronedarone—Rash—Sunitinib—kidney cancer	0.000273	0.00126	CcSEcCtD
Dronedarone—Dermatitis—Sunitinib—kidney cancer	0.000273	0.00126	CcSEcCtD
Dronedarone—Nausea—Sorafenib—kidney cancer	0.000268	0.00123	CcSEcCtD
Dronedarone—Asthenia—Vincristine—kidney cancer	0.000263	0.00121	CcSEcCtD
Dronedarone—Vomiting—Dactinomycin—kidney cancer	0.000261	0.0012	CcSEcCtD
Dronedarone—Rash—Dactinomycin—kidney cancer	0.000259	0.00119	CcSEcCtD
Dronedarone—Nausea—Sunitinib—kidney cancer	0.000258	0.00119	CcSEcCtD
Dronedarone—ABCB1—renal system—kidney cancer	0.000257	0.00874	CbGeAlD
Dronedarone—Dyspepsia—Paclitaxel—kidney cancer	0.000256	0.00118	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000252	0.00116	CcSEcCtD
Dronedarone—Fatigue—Paclitaxel—kidney cancer	0.000251	0.00116	CcSEcCtD
Dronedarone—Diarrhoea—Vincristine—kidney cancer	0.000251	0.00116	CcSEcCtD
Dronedarone—Asthenia—Gemcitabine—kidney cancer	0.00025	0.00115	CcSEcCtD
Dronedarone—ABCB1—kidney—kidney cancer	0.000249	0.00845	CbGeAlD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000248	0.00114	CcSEcCtD
Dronedarone—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000247	0.00114	CcSEcCtD
Dronedarone—Pruritus—Gemcitabine—kidney cancer	0.000246	0.00113	CcSEcCtD
Dronedarone—Nausea—Dactinomycin—kidney cancer	0.000244	0.00112	CcSEcCtD
Dronedarone—Pneumonia—Doxorubicin—kidney cancer	0.000243	0.00112	CcSEcCtD
Dronedarone—ABCB1—cortex of kidney—kidney cancer	0.000242	0.00823	CbGeAlD
Dronedarone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000238	0.0011	CcSEcCtD
Dronedarone—Diarrhoea—Gemcitabine—kidney cancer	0.000238	0.0011	CcSEcCtD
Dronedarone—Nervous system disorder—Capecitabine—kidney cancer	0.000234	0.00108	CcSEcCtD
Dronedarone—Vomiting—Vincristine—kidney cancer	0.000233	0.00107	CcSEcCtD
Dronedarone—Skin disorder—Capecitabine—kidney cancer	0.000232	0.00107	CcSEcCtD
Dronedarone—Rash—Vincristine—kidney cancer	0.000231	0.00107	CcSEcCtD
Dronedarone—Dermatitis—Vincristine—kidney cancer	0.000231	0.00106	CcSEcCtD
Dronedarone—ABCB1—gonad—kidney cancer	0.000231	0.00783	CbGeAlD
Dronedarone—Abdominal pain—Paclitaxel—kidney cancer	0.00023	0.00106	CcSEcCtD
Dronedarone—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000229	0.00105	CcSEcCtD
Dronedarone—Vomiting—Gemcitabine—kidney cancer	0.000221	0.00102	CcSEcCtD
Dronedarone—Bradycardia—Doxorubicin—kidney cancer	0.000221	0.00102	CcSEcCtD
Dronedarone—Rash—Gemcitabine—kidney cancer	0.000219	0.00101	CcSEcCtD
Dronedarone—Dermatitis—Gemcitabine—kidney cancer	0.000219	0.00101	CcSEcCtD
Dronedarone—Nausea—Vincristine—kidney cancer	0.000218	0.001	CcSEcCtD
Dronedarone—Dyspepsia—Capecitabine—kidney cancer	0.00021	0.00097	CcSEcCtD
Dronedarone—Asthenia—Paclitaxel—kidney cancer	0.000209	0.000963	CcSEcCtD
Dronedarone—Nausea—Gemcitabine—kidney cancer	0.000207	0.000952	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000206	0.000951	CcSEcCtD
Dronedarone—Fatigue—Capecitabine—kidney cancer	0.000206	0.00095	CcSEcCtD
Dronedarone—Pruritus—Paclitaxel—kidney cancer	0.000206	0.00095	CcSEcCtD
Dronedarone—Cardiac disorder—Doxorubicin—kidney cancer	0.000201	0.000927	CcSEcCtD
Dronedarone—Diarrhoea—Paclitaxel—kidney cancer	0.000199	0.000918	CcSEcCtD
Dronedarone—Angiopathy—Doxorubicin—kidney cancer	0.000197	0.000907	CcSEcCtD
Dronedarone—Immune system disorder—Doxorubicin—kidney cancer	0.000196	0.000903	CcSEcCtD
Dronedarone—Gastrointestinal pain—Capecitabine—kidney cancer	0.000196	0.000901	CcSEcCtD
Dronedarone—Mediastinal disorder—Doxorubicin—kidney cancer	0.000196	0.000901	CcSEcCtD
Dronedarone—Abdominal pain—Capecitabine—kidney cancer	0.000189	0.000871	CcSEcCtD
Dronedarone—Erythema—Doxorubicin—kidney cancer	0.000189	0.00087	CcSEcCtD
Dronedarone—Vomiting—Paclitaxel—kidney cancer	0.000185	0.000853	CcSEcCtD
Dronedarone—Dysgeusia—Doxorubicin—kidney cancer	0.000185	0.000852	CcSEcCtD
Dronedarone—Rash—Paclitaxel—kidney cancer	0.000184	0.000846	CcSEcCtD
Dronedarone—Dermatitis—Paclitaxel—kidney cancer	0.000184	0.000845	CcSEcCtD
Dronedarone—Nausea—Paclitaxel—kidney cancer	0.000173	0.000797	CcSEcCtD
Dronedarone—Asthenia—Capecitabine—kidney cancer	0.000172	0.00079	CcSEcCtD
Dronedarone—Pruritus—Capecitabine—kidney cancer	0.000169	0.000779	CcSEcCtD
Dronedarone—Diarrhoea—Capecitabine—kidney cancer	0.000164	0.000754	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.00016	0.000736	CcSEcCtD
Dronedarone—Anaphylactic shock—Doxorubicin—kidney cancer	0.000154	0.00071	CcSEcCtD
Dronedarone—Vomiting—Capecitabine—kidney cancer	0.000152	0.0007	CcSEcCtD
Dronedarone—Nervous system disorder—Doxorubicin—kidney cancer	0.000151	0.000696	CcSEcCtD
Dronedarone—Rash—Capecitabine—kidney cancer	0.000151	0.000694	CcSEcCtD
Dronedarone—Dermatitis—Capecitabine—kidney cancer	0.000151	0.000694	CcSEcCtD
Dronedarone—Skin disorder—Doxorubicin—kidney cancer	0.00015	0.00069	CcSEcCtD
Dronedarone—Nausea—Capecitabine—kidney cancer	0.000142	0.000654	CcSEcCtD
Dronedarone—Dyspepsia—Doxorubicin—kidney cancer	0.000136	0.000625	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000133	0.000613	CcSEcCtD
Dronedarone—Fatigue—Doxorubicin—kidney cancer	0.000133	0.000612	CcSEcCtD
Dronedarone—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000126	0.000581	CcSEcCtD
Dronedarone—Abdominal pain—Doxorubicin—kidney cancer	0.000122	0.000561	CcSEcCtD
Dronedarone—Asthenia—Doxorubicin—kidney cancer	0.000111	0.000509	CcSEcCtD
Dronedarone—Pruritus—Doxorubicin—kidney cancer	0.000109	0.000502	CcSEcCtD
Dronedarone—Diarrhoea—Doxorubicin—kidney cancer	0.000105	0.000486	CcSEcCtD
Dronedarone—Vomiting—Doxorubicin—kidney cancer	9.8e-05	0.000451	CcSEcCtD
Dronedarone—Rash—Doxorubicin—kidney cancer	9.72e-05	0.000448	CcSEcCtD
Dronedarone—Dermatitis—Doxorubicin—kidney cancer	9.71e-05	0.000447	CcSEcCtD
Dronedarone—Nausea—Doxorubicin—kidney cancer	9.15e-05	0.000422	CcSEcCtD
Dronedarone—ADRA2A—Hemostasis—PIK3CA—kidney cancer	6.81e-06	4.82e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HIF1A—kidney cancer	6.8e-06	4.81e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—BRAF—kidney cancer	6.79e-06	4.8e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TSC2—kidney cancer	6.78e-06	4.8e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—SLC2A1—kidney cancer	6.77e-06	4.79e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KDR—kidney cancer	6.61e-06	4.67e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—TP53—kidney cancer	6.59e-06	4.66e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—MAPK1—kidney cancer	6.58e-06	4.65e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—APC—kidney cancer	6.58e-06	4.65e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KIT—kidney cancer	6.58e-06	4.65e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—RAF1—kidney cancer	6.57e-06	4.64e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—APC—kidney cancer	6.52e-06	4.61e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KIT—kidney cancer	6.52e-06	4.61e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—MAPK3—kidney cancer	6.51e-06	4.6e-05	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—PIK3CA—kidney cancer	6.51e-06	4.6e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KDR—kidney cancer	6.5e-06	4.6e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—IL2—kidney cancer	6.49e-06	4.59e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—ABCB1—kidney cancer	6.47e-06	4.58e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL2—kidney cancer	6.34e-06	4.48e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—MAPK3—kidney cancer	6.3e-06	4.45e-05	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—PIK3CA—kidney cancer	6.29e-06	4.44e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GSTM1—kidney cancer	6.29e-06	4.44e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CRABP1—kidney cancer	6.28e-06	4.44e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—POMC—kidney cancer	6.26e-06	4.43e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—MAPK3—kidney cancer	6.24e-06	4.41e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—KRAS—kidney cancer	6.21e-06	4.39e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—POMC—kidney cancer	6.2e-06	4.39e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—MAPK1—kidney cancer	6.2e-06	4.38e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—BRAF—kidney cancer	6.18e-06	4.37e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—BRAF—kidney cancer	6.13e-06	4.33e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—APC—kidney cancer	6.09e-06	4.3e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KIT—kidney cancer	6.09e-06	4.3e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HIF1A—kidney cancer	6.04e-06	4.27e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TSC2—kidney cancer	6.03e-06	4.26e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—MAPK1—kidney cancer	5.99e-06	4.24e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTP1—kidney cancer	5.99e-06	4.24e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—APC—kidney cancer	5.99e-06	4.24e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KIT—kidney cancer	5.99e-06	4.24e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYP1A1—kidney cancer	5.96e-06	4.21e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—MAPK1—kidney cancer	5.94e-06	4.2e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL2—kidney cancer	5.89e-06	4.16e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—KRAS—kidney cancer	5.85e-06	4.14e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ITPR2—kidney cancer	5.84e-06	4.13e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—MAPK3—kidney cancer	5.83e-06	4.12e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—POMC—kidney cancer	5.8e-06	4.1e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KDR—kidney cancer	5.78e-06	4.08e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—MAPK3—kidney cancer	5.74e-06	4.06e-05	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—PIK3CA—kidney cancer	5.73e-06	4.05e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—BRAF—kidney cancer	5.72e-06	4.05e-05	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—PIK3CA—kidney cancer	5.72e-06	4.04e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—PIK3CA—kidney cancer	5.71e-06	4.04e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—POMC—kidney cancer	5.7e-06	4.03e-05	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—PIK3CA—kidney cancer	5.68e-06	4.01e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—RAF1—kidney cancer	5.67e-06	4.01e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—KRAS—kidney cancer	5.66e-06	4e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTP1—kidney cancer	5.65e-06	3.99e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—RELA—kidney cancer	5.64e-06	3.99e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—BRAF—kidney cancer	5.63e-06	3.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—POMC—kidney cancer	5.63e-06	3.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HIF1A—kidney cancer	5.61e-06	3.97e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—KRAS—kidney cancer	5.61e-06	3.97e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—ERBB2—kidney cancer	5.61e-06	3.96e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TSC2—kidney cancer	5.6e-06	3.96e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—MAPK1—kidney cancer	5.55e-06	3.92e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MTOR—kidney cancer	5.53e-06	3.91e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTGS2—kidney cancer	5.53e-06	3.91e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTM1—kidney cancer	5.51e-06	3.89e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—MAPK1—kidney cancer	5.46e-06	3.86e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—PIK3CA—kidney cancer	5.38e-06	3.8e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KDR—kidney cancer	5.37e-06	3.8e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ABCB1—kidney cancer	5.35e-06	3.78e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTT1—kidney cancer	5.33e-06	3.77e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ACHE—kidney cancer	5.33e-06	3.77e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—APC—kidney cancer	5.32e-06	3.76e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KIT—kidney cancer	5.32e-06	3.76e-05	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—PIK3CA—kidney cancer	5.3e-06	3.75e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—KRAS—kidney cancer	5.24e-06	3.7e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYP1A1—kidney cancer	5.22e-06	3.69e-05	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—PIK3CA—kidney cancer	5.22e-06	3.69e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—TP53—kidney cancer	5.2e-06	3.68e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—PIK3CA—kidney cancer	5.2e-06	3.68e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CDKN1B—kidney cancer	5.19e-06	3.67e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTM1—kidney cancer	5.19e-06	3.67e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—RAF1—kidney cancer	5.16e-06	3.65e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—KRAS—kidney cancer	5.16e-06	3.65e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—PIK3CA—kidney cancer	5.15e-06	3.64e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—RELA—kidney cancer	5.14e-06	3.63e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—RAF1—kidney cancer	5.12e-06	3.62e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—ERBB2—kidney cancer	5.11e-06	3.61e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	5.1e-06	3.6e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—RELA—kidney cancer	5.09e-06	3.6e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL2—kidney cancer	5.08e-06	3.59e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—POMC—kidney cancer	5.07e-06	3.58e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—ERBB2—kidney cancer	5.06e-06	3.58e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SCARB1—kidney cancer	5.04e-06	3.57e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MTOR—kidney cancer	5.04e-06	3.56e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—BRAF—kidney cancer	5e-06	3.54e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MTOR—kidney cancer	4.99e-06	3.53e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS1—kidney cancer	4.99e-06	3.53e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCND1—kidney cancer	4.95e-06	3.5e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—APC—kidney cancer	4.95e-06	3.5e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KIT—kidney cancer	4.95e-06	3.5e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—JUN—kidney cancer	4.94e-06	3.49e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.92e-06	3.48e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CTNNB1—kidney cancer	4.9e-06	3.47e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.9e-06	3.46e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PSMD7—kidney cancer	4.9e-06	3.46e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	4.85e-06	3.43e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTEN—kidney cancer	4.82e-06	3.41e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—PIK3CA—kidney cancer	4.81e-06	3.4e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PTEN—kidney cancer	4.78e-06	3.38e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—RAF1—kidney cancer	4.78e-06	3.38e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—RELA—kidney cancer	4.76e-06	3.36e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	4.74e-06	3.35e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	4.74e-06	3.35e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CDKN1B—kidney cancer	4.73e-06	3.34e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—ERBB2—kidney cancer	4.73e-06	3.34e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—POMC—kidney cancer	4.71e-06	3.33e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—RAF1—kidney cancer	4.7e-06	3.32e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CDKN1B—kidney cancer	4.69e-06	3.31e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—RELA—kidney cancer	4.68e-06	3.31e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MTOR—kidney cancer	4.67e-06	3.3e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	4.65e-06	3.29e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—BRAF—kidney cancer	4.65e-06	3.29e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—BCHE—kidney cancer	4.64e-06	3.28e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	4.63e-06	3.28e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL2—kidney cancer	4.63e-06	3.27e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MTOR—kidney cancer	4.59e-06	3.25e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL2—kidney cancer	4.59e-06	3.24e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.58e-06	3.24e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	4.58e-06	3.24e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCND1—kidney cancer	4.51e-06	3.19e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	4.51e-06	3.19e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—JUN—kidney cancer	4.5e-06	3.18e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—kidney cancer	4.49e-06	3.17e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCND1—kidney cancer	4.47e-06	3.16e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CTNNB1—kidney cancer	4.47e-06	3.16e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—JUN—kidney cancer	4.46e-06	3.15e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—POMC—kidney cancer	4.44e-06	3.14e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CTNNB1—kidney cancer	4.43e-06	3.13e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.43e-06	3.13e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CDKN1B—kidney cancer	4.38e-06	3.1e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTEN—kidney cancer	4.36e-06	3.08e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—kidney cancer	4.32e-06	3.05e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTEN—kidney cancer	4.32e-06	3.05e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	4.31e-06	3.05e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	4.31e-06	3.04e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL2—kidney cancer	4.28e-06	3.03e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	4.26e-06	3.01e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL2—kidney cancer	4.22e-06	2.98e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	4.21e-06	2.98e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—RAF1—kidney cancer	4.18e-06	2.95e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCND1—kidney cancer	4.18e-06	2.95e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—JUN—kidney cancer	4.17e-06	2.95e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—RELA—kidney cancer	4.16e-06	2.94e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	4.14e-06	2.92e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	4.13e-06	2.92e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCND1—kidney cancer	4.11e-06	2.91e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—JUN—kidney cancer	4.1e-06	2.9e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	4.08e-06	2.89e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MTOR—kidney cancer	4.08e-06	2.88e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	4.07e-06	2.88e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTEN—kidney cancer	4.03e-06	2.85e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MYC—kidney cancer	3.97e-06	2.81e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTEN—kidney cancer	3.97e-06	2.8e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—kidney cancer	3.93e-06	2.78e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTEN—kidney cancer	3.92e-06	2.77e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	3.91e-06	2.76e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	3.9e-06	2.76e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—POMC—kidney cancer	3.89e-06	2.75e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	3.89e-06	2.75e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—RAF1—kidney cancer	3.88e-06	2.74e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—RELA—kidney cancer	3.86e-06	2.73e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	3.84e-06	2.71e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	3.83e-06	2.71e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MTOR—kidney cancer	3.79e-06	2.68e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL2—kidney cancer	3.75e-06	2.65e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK3—kidney cancer	3.72e-06	2.63e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTP1—kidney cancer	3.69e-06	2.61e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	3.69e-06	2.61e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KRAS—kidney cancer	3.67e-06	2.6e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—POMC—kidney cancer	3.67e-06	2.59e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCND1—kidney cancer	3.65e-06	2.58e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—JUN—kidney cancer	3.64e-06	2.58e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	3.64e-06	2.57e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MYC—kidney cancer	3.62e-06	2.56e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	3.62e-06	2.56e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MYC—kidney cancer	3.59e-06	2.54e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	3.58e-06	2.53e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	3.56e-06	2.51e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—kidney cancer	3.54e-06	2.51e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK1—kidney cancer	3.54e-06	2.5e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTEN—kidney cancer	3.52e-06	2.49e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	3.51e-06	2.48e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ABCB1—kidney cancer	3.5e-06	2.47e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL2—kidney cancer	3.48e-06	2.46e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	3.44e-06	2.44e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PIK3CA—kidney cancer	3.4e-06	2.4e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTM1—kidney cancer	3.39e-06	2.4e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCND1—kidney cancer	3.39e-06	2.4e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	3.39e-06	2.4e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—JUN—kidney cancer	3.39e-06	2.39e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	3.37e-06	2.38e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	3.36e-06	2.38e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MYC—kidney cancer	3.35e-06	2.37e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KRAS—kidney cancer	3.34e-06	2.36e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KRAS—kidney cancer	3.31e-06	2.34e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MYC—kidney cancer	3.3e-06	2.33e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	3.28e-06	2.32e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTEN—kidney cancer	3.27e-06	2.31e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—kidney cancer	3.26e-06	2.31e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	3.23e-06	2.28e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.22e-06	2.27e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	3.18e-06	2.25e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—kidney cancer	3.1e-06	2.2e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KRAS—kidney cancer	3.1e-06	2.19e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTEN—kidney cancer	3.09e-06	2.18e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PIK3CA—kidney cancer	3.07e-06	2.17e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KRAS—kidney cancer	3.05e-06	2.15e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	3.04e-06	2.15e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	3.01e-06	2.13e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—kidney cancer	2.97e-06	2.1e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	2.96e-06	2.09e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—kidney cancer	2.95e-06	2.08e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MYC—kidney cancer	2.93e-06	2.07e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—kidney cancer	2.93e-06	2.07e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	2.86e-06	2.03e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	2.84e-06	2.01e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	2.8e-06	1.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	2.8e-06	1.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CA—kidney cancer	2.76e-06	1.95e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—kidney cancer	2.75e-06	1.95e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MYC—kidney cancer	2.72e-06	1.92e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTEN—kidney cancer	2.71e-06	1.91e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—kidney cancer	2.71e-06	1.91e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KRAS—kidney cancer	2.71e-06	1.91e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	2.66e-06	1.88e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTEN—kidney cancer	2.55e-06	1.8e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KRAS—kidney cancer	2.51e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	2.49e-06	1.76e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—kidney cancer	2.41e-06	1.7e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—POMC—kidney cancer	2.4e-06	1.7e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	2.31e-06	1.63e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—kidney cancer	2.23e-06	1.58e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CA—kidney cancer	2.18e-06	1.54e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.91e-06	1.35e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CA—kidney cancer	1.91e-06	1.35e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.8e-06	1.27e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTEN—kidney cancer	1.67e-06	1.18e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.18e-06	8.32e-06	CbGpPWpGaD
